MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$94,064K Marketable securities$61,458K Prepaid expenses andother current assets$4,623K Total current assets$160,145K Long-term equityinvestments$41,961K Right-of-use asset, net$11,298K Marketable securities -noncurrent$10,076K Restricted cash$1,931K Property and equipment,net$217K Total assets$225,628K Total liabilities andstockholders equity$225,628K Total stockholdersequity$198,269K Total liabilities$27,359K Accumulated deficit-$338,701K Accumulated othercomprehensive loss-$422K Additionalpaid-in-capital$537,225K Total currentliabilities$15,748K Lease liability$11,611K Common stock, 0.001 parvalue 315,000,000...$167K Accounts payable$8,876K Accrued expenses$5,413K Current portion, leaseliability$1,459K
Balance Sheet

Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Inc. (OVID)

source: myfinsight.com